Example: Heart Attack

Clinical Trials on Hematologic Neoplasms

Total 90 results

  • NCT03219268
    Recruiting
    A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
    Conditions: Advanced Solid Tumors, Hematologic Neoplasms, Ovarian Cancer, HER2-positive Breast Cancer, Non Small Cell Lung Cancer, Small-cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck, Cholangiocarcinoma, Cervical Cancer, TNBC - Triple-Negative Breast Cancer
  • NCT02329847
    Active, not recruiting
    A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies
    Conditions: Hematologic Neoplasms
  • NCT00071045
    Recruiting
    Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
    Conditions: Neoplasms, Hematologic Neoplasms, Healthy Volunteers
  • NCT03983850
    Recruiting
    Optimizing PTCy Dose and Timing
    Conditions: Graft Versus Host Disease, Hematologic Neoplasms
  • NCT01553461
    Recruiting
    Transplants With Unlicensed Preserved Cord Blood
    Conditions: Myelodysplastic Syndrome (MDS), Hematologic Neoplasms, Hematologic Diseases, Severe Aplastic Anemia
  • NCT04448184
    Not yet recruiting
    Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH Trial)
    Conditions: Hematologic Neoplasms
  • NCT04760184
    Recruiting
    Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden
    Conditions: Covid19, Myeloma Multiple, Malignant Lymphoma, Hematologic Neoplasms, Stem Cell Transplant Complications
  • NCT04266093
    Recruiting
    Gene Therapy Follow up for Subjects Previously Enrolled in NCI Genitourinary Malignancies Branch Studies
    Conditions: Cervical Intraepithelial Neoplasia, Cervical Neoplasms, Oropharyngeal Neoplasms, Squamous Intraepithelial Lesions of the Cervix, Hematologic Malignacies
  • NCT03735992
    Recruiting
    Mind-body Medicine for Patients With Malignant Hematological Diseases
    Conditions: Hematologic Neoplasms
  • NCT04871165
    Recruiting
    Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
    Conditions: Hematologic Neoplasms, COVID-19 Vaccines
  • NCT04264767
    Active, not recruiting
    Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA
    Conditions: Cancer, Solid Tumor, Hematologic Neoplasms
  • NCT03083327
    Recruiting
    Prophylactic Early PN in HPT/BMT
    Conditions: Hematologic Neoplasms
  • NCT03094026
    Recruiting
    Cognitive Training Intervention and Attitudes Towards Genetics
    Conditions: Cognitive Impairment, Hematologic Neoplasms, Hematopoietic Cell Transplant
  • NCT04309084
    Recruiting
    Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
    Conditions: Multiple Myeloma, Neoplasm, Plasma Cell, Neoplasms by Histologic Type, Neoplasms, Hemostatic Disorder, Vascular Diseases, Cardiovascular Diseases, Paraproteinemias, Blood Protein Disorders, Hematologic Diseases, Hemorrhagic Disorders, Lymphoproliferative Disorders, Immunoproliferative Disorders, Immune System Diseases, Antineoplastic Agents, Analgesics, Non-Narcotic, Analgesics, Sensory System Agents, Peripheral Nervous System Agents, Physiological Effects of Drugs
  • NCT03648372
    Recruiting
    A Study of TAK-981 in Participants With Relapsed/Refractory Solid Tumors or Non-Hodgkin Lymphoma (NHL)
    Conditions: Neoplasms, Lymphoma, Hematologic Neoplasms
  • NCT01869218
    Completed
    Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy
    Conditions: Hematologic Neoplasms
  • NCT03722186
    Suspended
    Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies
    Conditions: Physiological Effects of Drugs, Neoplasms by Histologic Type, Lymphoma, Hematologic Neoplasms, Immunotherapy, Advanced Cancer
  • NCT03023202
    Recruiting
    UWCCC Molecular Tumor Board Registry
    Conditions: Hematologic Neoplasms, Solid Neoplasm
  • NCT03680092
    Recruiting
    Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation in Patients With Hematologic Malignancy
    Conditions: GVHD, Hematologic Neoplasms
  • NCT04691284
    Recruiting
    Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation
    Conditions: Hematologic Neoplasms
  • NCT03136445
    Recruiting
    TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia
    Conditions: Hematologic Neoplasms, Hemorrhage, Hematopoietic Stem Cell Transplantation
  • NCT04039100
    Recruiting
    Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease
    Conditions: Multiple Myeloma, Lymphoma, Bone Marrow Transplantation, Neoplasms, Hematologic Diseases, Leukemia, Myeloid
  • NCT04310592
    Recruiting
    Natural Killer Cell (CYNK-001) Infusions in Adults With AML
    Conditions: Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute, Neoplasms by Histologic Type, Neoplasms, Immunosuppressive Agents, Immunologic Factors, Physiological Effects of Drugs, Alkylating Agents, Antimetabolites, Antineoplastic, Antiviral Agents, Analgesics, Non-narcotic, Anti-infective Agents, Analgesics, Peripheral Nervous System Agents, Hematologic Diseases, Hematologic Neoplasms, Leukemia in Remission
  • NCT02494258
    Active, not recruiting
    A Study to Evaluate Long-term Safety in Subjects With Solid Tumors and Hematological Disorders.
    Conditions: Hematologic Neoplasm, Neoplasms
  • NCT00526045
    Completed
    Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients
    Conditions: Breast Cancer, Hematologic Neoplasms
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations